• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

猪流感的大流行及其可能的药物治疗。

Pandemism of swine flu and its prospective drug therapy.

机构信息

Department of Microbiology, University of Delhi South Campus, Benito Juarez Road, New Delhi, 110021, India.

出版信息

Eur J Clin Microbiol Infect Dis. 2012 Dec;31(12):3265-79. doi: 10.1007/s10096-012-1716-5. Epub 2012 Aug 16.

DOI:10.1007/s10096-012-1716-5
PMID:22895890
Abstract

Swine flu is a respiratory disease caused by influenza A H1N1 virus. The current pandemic of swine flu is most probably due to a mutation-more specifically, a re-assortment of four known strains of influenza A virus subtype H1N1. Antigenic variation of influenza viruses while circulating in the population is an important factor leading to difficulties in controlling influenza by vaccination. Due to the global effect of swine flu and its effect on humans, extensive investigations are being undertaken. In this context, Tamiflu is the only available drug used in the prophylaxis of this disease and is made from the compound shikimic acid. Due to the sudden increase in the demand of shikimic acid, its price has increased greatly. Thus, it is necessary to find an alternative approach for the treatment of swine flu. This review presents the overall information of swine flu, beginning from its emergence to the prevention and treatment of the disease, with a major emphasis on the alternative approach (bacterial fermentation process) for the treatment of swine flu. The alternative approach for the treatment of swine flu includes the production of shikimic acid from a fermentation process and it can be produced in large quantities without any time limitations.

摘要

猪流感是由甲型 H1N1 流感病毒引起的呼吸道疾病。当前的猪流感大流行很可能是由于一种突变——更具体地说,是四种已知的甲型 H1N1 流感病毒亚型的重组。流感病毒在人群中传播时的抗原变异是导致通过疫苗接种控制流感困难的一个重要因素。由于猪流感的全球影响及其对人类的影响,正在进行广泛的调查。在这种情况下,达菲是预防这种疾病唯一可用的药物,它是由莽草酸制成的。由于莽草酸的需求突然增加,其价格大幅上涨。因此,有必要寻找一种替代方法来治疗猪流感。本文综述了猪流感的整体信息,从其出现到疾病的预防和治疗,重点介绍了治疗猪流感的替代方法(细菌发酵工艺)。治疗猪流感的替代方法包括通过发酵过程生产莽草酸,并且可以在没有任何时间限制的情况下大量生产。

相似文献

1
Pandemism of swine flu and its prospective drug therapy.猪流感的大流行及其可能的药物治疗。
Eur J Clin Microbiol Infect Dis. 2012 Dec;31(12):3265-79. doi: 10.1007/s10096-012-1716-5. Epub 2012 Aug 16.
2
Expanding horizons of shikimic acid. Recent progresses in production and its endless frontiers in application and market trends.拓展莽草酸的视野。生产方面的最新进展及其在应用和市场趋势方面的无尽前沿。
Appl Microbiol Biotechnol. 2013 May;97(10):4277-87. doi: 10.1007/s00253-013-4840-y. Epub 2013 Apr 5.
3
An influenza A H1N1 virus revival - pandemic H1N1/09 virus.甲型 H1N1 流感病毒重现——大流行 H1N1/09 病毒。
Infection. 2009 Oct;37(5):381-9. doi: 10.1007/s15010-009-9181-5. Epub 2009 Sep 18.
4
Bird flu, swine flu, and resistant influenza: the scary development of antiviral-resistant strains-part 2: novel A(H1N1): the flu we never expected.禽流感、猪流感与耐药流感:抗病毒耐药毒株的可怕演变——第二部分:新型甲型H1N1流感:我们始料未及的流感
Clin Nurse Spec. 2009 Nov-Dec;23(6):293-5. doi: 10.1097/NUR.0b013e3181bc3257.
5
Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir.应对 2009 年流感大流行(H1N1):奥司他韦的作用。
J Antimicrob Chemother. 2010 Apr;65 Suppl 2(Suppl 2):ii35-ii40. doi: 10.1093/jac/dkq014.
6
UK swine flu cases near 3000, as GP leader says use of Tamiflu may need to be rethought.英国猪流感病例接近3000例,全科医生负责人表示可能需要重新考虑达菲的使用。
BMJ. 2009 Jun 23;338:b2565. doi: 10.1136/bmj.b2565.
7
Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.探究奥司他韦(达菲)与2009年甲型H1N1流感病毒神经氨酸酶相互作用的见解。
Biochem Biophys Res Commun. 2009 Aug 28;386(3):432-6. doi: 10.1016/j.bbrc.2009.06.016. Epub 2009 Jun 10.
8
Knowledge gaps about Tamiflu and Relenza for pandemic flu are blamed on research failure.对于大流行性流感使用达菲和瑞乐沙的知识空白被归咎于研究失败。
BMJ. 2015 Oct 8;351:h5390. doi: 10.1136/bmj.h5390.
9
[Pandemic influenza in Russia: specific features of clinical course and the absence of early etiotropic therapy as a risk factor of severe forms of the disease].[俄罗斯的大流行性流感:临床病程的特点以及缺乏早期病因特异性治疗作为疾病严重形式的危险因素]
Ter Arkh. 2011;83(9):48-53.
10
Pandemic influenza A(H1N1)2009 in hospital healthcare workers in New Zealand.新西兰医院医护人员中的 2009 年甲型 H1N1 流感大流行。
Infect Control Hosp Epidemiol. 2012 Feb;33(2):196-9. doi: 10.1086/663705. Epub 2011 Dec 23.

引用本文的文献

1
A comprehensive perspective of traditional Arabic or Islamic medicinal plants as an adjuvant therapy against COVID-19.关于传统阿拉伯或伊斯兰药用植物作为对抗COVID-19辅助疗法的全面观点。
Saudi J Biol Sci. 2023 Mar;30(3):103561. doi: 10.1016/j.sjbs.2023.103561. Epub 2023 Jan 13.
2
Metabolic Engineering of Shikimic Acid Biosynthesis Pathway for the Production of Shikimic Acid and Its Branched Products in Microorganisms: Advances and Prospects.微生物中莽草酸生物合成途径的代谢工程生产莽草酸及其支链产物:进展与展望。
Molecules. 2022 Jul 26;27(15):4779. doi: 10.3390/molecules27154779.
3
Assistance of DFT calculations on the design and rationalization of active pharmaceutical ingredients synthesis - Michael addition-isomerization steps in Oseltamivir synthesis.

本文引用的文献

1
Large-scale evolutionary surveillance of the 2009 H1N1 influenza A virus using resequencing arrays.利用重测序芯片对 2009 年 H1N1 流感病毒进行大规模进化监测。
Nucleic Acids Res. 2010 May;38(9):e111. doi: 10.1093/nar/gkq089. Epub 2010 Feb 25.
2
Influenza epidemiology--past, present, and future.流感流行病学——过去、现在和未来。
Crit Care Med. 2010 Apr;38(4 Suppl):e1-9. doi: 10.1097/CCM.0b013e3181cbaf34.
3
Swine flu.猪流感
密度泛函理论计算对活性药物成分合成设计及合理化的辅助作用——奥司他韦合成中的迈克尔加成-异构化步骤
Tetrahedron. 2020 Dec 18;76(51):131373. doi: 10.1016/j.tet.2020.131373. Epub 2020 Jul 6.
4
Treating a Global Health Crisis with a Dose of Synthetic Chemistry.用一剂合成化学药物应对全球健康危机。
ACS Cent Sci. 2020 Jul 22;6(7):1017-1030. doi: 10.1021/acscentsci.0c00637. Epub 2020 Jun 30.
5
Novel technologies combined with traditional metabolic engineering strategies facilitate the construction of shikimate-producing Escherichia coli.新型技术与传统代谢工程策略相结合,促进了芳香族氨基酸生产大肠杆菌的构建。
Microb Cell Fact. 2017 Sep 29;16(1):167. doi: 10.1186/s12934-017-0773-y.
6
Metabolic engineering of Escherichia coli to enhance shikimic acid production from sorbitol.对大肠杆菌进行代谢工程改造以提高山梨醇生成莽草酸的产量。
World J Microbiol Biotechnol. 2014 Sep;30(9):2543-50. doi: 10.1007/s11274-014-1679-z. Epub 2014 Jun 4.
Croat Med J. 2009 Aug;50(4):412-5. doi: 10.3325/cmj.2009.50.412.
4
Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets.猪源2009甲型(H1N1)流感病毒在雪貂体内的发病机制与传播
Science. 2009 Jul 24;325(5939):481-3. doi: 10.1126/science.1177127. Epub 2009 Jul 2.
5
Oseltamivir- and amantadine-resistant influenza viruses A (H1N1).对奥司他韦和金刚烷胺耐药的甲型H1N1流感病毒
Emerg Infect Dis. 2009 Jun;15(6):966-8. doi: 10.3201/eid1506.081357.
6
Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans.在人群中传播的源自猪的2009年甲型H1N1流感病毒的抗原和基因特征
Science. 2009 Jul 10;325(5937):197-201. doi: 10.1126/science.1176225. Epub 2009 May 22.
7
Pandemic potential of a strain of influenza A (H1N1): early findings.甲型H1N1流感病毒株的大流行潜力:早期发现。
Science. 2009 Jun 19;324(5934):1557-61. doi: 10.1126/science.1176062. Epub 2009 May 11.
8
Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009.2005 - 2009年美国人类感染的三重重配甲型H1流感病毒
N Engl J Med. 2009 Jun 18;360(25):2616-25. doi: 10.1056/NEJMoa0903812. Epub 2009 May 7.
9
The origin of the recent swine influenza A(H1N1) virus infecting humans.近期感染人类的甲型H1N1猪流感病毒的起源。
Euro Surveill. 2009 Apr 30;14(17):19193.
10
Towards a sane and rational approach to management of Influenza H1N1 2009.迈向对2009年甲型H1N1流感进行合理且理性管理的方法
Virol J. 2009 May 7;6:51. doi: 10.1186/1743-422X-6-51.